![Niclas Stiernholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Niclas Stiernholm
Director/Board Member at
Ontario Bioscience Industry Organization
Profile
Niclas Stiernholm is currently Director at Tarix Pharmaceuticals Ltd., Ontario Bioscience Industry Organization, and Vasomune Therapeutics, Inc. Former roles include President, Chief Executive Officer & Director at Trillium Therapeutics, Inc. from 2013 to 2019, Chief Executive Officer & Director at Trillium Therapeutics, Inc. from 2011 to 2014, Director at AIM Therapeutics, Inc., Ontario Genomics Institute (Private Equity), and Bristol-Myers Squibb FCT bêta, Inc., Chief Scientific Officer & Executive VP at YM BioSciences, Inc. in 2002, Manager-Business Development at Allelix Biopharmaceuticals, Inc. in 1999, and Executive In Residence at Fight Against Cancer Innovation Trust.
Education includes undergraduate studies at Elon University and a doctorate from the University of Toronto.
Niclas Stiernholm active positions
| Companies | Position | Start |
|---|---|---|
Ontario Bioscience Industry Organization
 Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services Operates membership organization that engages in strategy, programming, policy development and advocacy | Director/Board Member | - |
Tarix Pharmaceuticals Ltd.
 Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops peptide drugs | Director/Board Member | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Director/Board Member | - |
Former positions of Niclas Stiernholm
| Companies | Position | End |
|---|---|---|
| TRILLIUM THERAPEUTICS | Chief Executive Officer | 29/04/2019 |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Chief Tech/Sci/R&D Officer | 01/10/2002 |
Allelix Biopharmaceuticals, Inc.
 Allelix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and neuropharmaceuticals | Corporate Officer/Principal | 01/01/1999 |
Fight Against Cancer Innovation Trust
 Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Private Equity Investor | - |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Director/Board Member | - |
Training of Niclas Stiernholm
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Allelix Biopharmaceuticals, Inc.
Allelix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and neuropharmaceuticals | Health Technology |
Elon University
 Elon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops peptide drugs | Health Technology |
AIM Therapeutics, Inc.
 AIM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody-based treatments for cancer and infectious diseases | Health Technology |
Ontario Genomics Institute (Private Equity)
 Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute invests in companies located in Canada. The firm targets companies operating in the fields of Human health, Agriculture & Food, Bioproducts & environment. | Finance |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services Operates membership organization that engages in strategy, programming, policy development and advocacy | Commercial Services |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-tumor activity medication treatment | Health Technology |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Health Technology |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust invests in companies located in Canada, primarily in Ontario. The firm targets companies operating in the fields of technology, therapeutics, imaging and diagnostics sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 1 - 5 million. It also makes follow-on investments. | Finance |
- Stock Market
- Insiders
- Niclas Stiernholm
